Cumberland Pharmaceuticals Valuation
| CPIX Stock | USD 3.91 0.32 8.91% |
At this time, the firm appears to be undervalued. Cumberland Pharmaceuticals shows a prevailing Real Value of $4.98 per share. The current price of the firm is $3.91. Our model approximates the value of Cumberland Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 48.74 M, return on equity of -0.13, and Profit Margin of (0.08) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cumberland Pharmaceuticals' valuation include:
Price Book 2.0557 | Enterprise Value | Enterprise Value Ebitda 16.4145 | Price Sales 1.417 | Enterprise Value Revenue 1.1807 |
Undervalued
Today
Please note that Cumberland Pharmaceuticals' price fluctuation is risky at this time. Calculation of the real value of Cumberland Pharmaceuticals is based on 3 months time horizon. Increasing Cumberland Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cumberland Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cumberland Stock. However, Cumberland Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.91 | Real 4.98 | Target 8.5 | Hype 3.65 |
The intrinsic value of Cumberland Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cumberland Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cumberland Pharmaceuticals helps investors to forecast how Cumberland stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cumberland Pharmaceuticals more accurately as focusing exclusively on Cumberland Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cumberland Pharmaceuticals' intrinsic value based on its ongoing forecasts of Cumberland Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cumberland Pharmaceuticals' closest peers.
Cumberland Pharmaceuticals Cash |
|
Cumberland Revenue by Product
About Cumberland Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Cumberland Pharmaceuticals. We calculate exposure to Cumberland Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cumberland Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 36 M | 33.9 M | |
| Pretax Profit Margin | (0.20) | (0.19) | |
| Operating Profit Margin | (0.20) | (0.19) | |
| Net Loss | (0.20) | (0.19) | |
| Gross Profit Margin | 0.95 | 0.94 |
Cumberland Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Cumberland Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cumberland we look at many different elements of the entity such as Cumberland's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cumberland Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cumberland Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cumberland Pharmaceuticals' worth.Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.